Robert P. Hasserjian
Harvard University
359 Papers
1.3K Citations
Robert P. Hasserjian is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Myeloid leukemia. The author has an hindex of 53, co-authored 284 publications. Previous affiliations of Robert P. Hasserjian include Hammersmith Hospital & Partners HealthCare.
Chat about Author
Papers
Computer-assisted quantification of CD3+ T cells in follicular lymphoma
Fazly Salleh Abas,Arwa Shana'ah,Beth A. Christian,Robert P. Hasserjian,Abner Louissaint,Michael L. Pennell,Berkman Sahiner,Weijie Chen,Muhammad Khalid Khan Niazi,Gerard Lozanski,Metin N. Gurcan +10 more
TL;DR: In the future, the computerized quantification method may be used to investigate the relationship between the overall architectural pattern (i.e., interfollicular vs. follicular) and outcome measures (e.g., overall survival, and time to treatment).
13
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia
Megan J. Fitzpatrick,Leonardo Boiocchi,Amir T. Fathi,Andrew M. Brunner,Robert P. Hasserjian,Valentina Nardi +5 more
TL;DR: This work sought to determine an optimal threshold of staining with p53 IHC to predict TP53‐mutational status and found it to be within 1 day of biopsy.
13
Extranodal natural killer T-cell lymphoma, nasal type, with minimal osseous involvement: report of a case and literature review.
Srinivas M. Susarla,Basel Sharaf,William C. Faquin,Robert P. Hasserjian,Nancy E. McDermott,Edward T. Lahey +5 more
TL;DR: The purposes of this case report are to describe an atypical presentation of ENKTCL involving primarily the soft tissues of the midface and to highlight the vigilance required in diagnosing this cause of nonresolving facial swelling.
13
Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1.
Chi Young Ok,Kevin T. Trowell,Kyle Parker,Karen A. Moser,Olga K. Weinberg,Heesun J. Rogers,Kaaren K. Reichard,Tracy I. George,Eric D. Hsi,Carlos E. Bueso-Ramos,Wayne Tam,Attilio Orazi,Adam Bagg,Daniel A. Arber,Robert P. Hasserjian,Sa A. Wang +15 more
TL;DR: This study shows that concomitant SF3B1 and MPN-driver mutations can be observed in MDS, MPN, and MDS/MPN-U, each showing overlapping but also distinctively different clinicopathological features.
13
Recurrences in nodal T-cell lymphoma. Changes in histologic appearance and immunophenotype over the course of disease.
Dan Jones,David Weissmann,Madeleine D. Kraus,Robert P. Hasserjian,Aliakbar Shahsafaei,David M. Dorfman +5 more
TL;DR: The majority of relapsed PTCLs retained a similar histologic appearance, pattern of nodal involvement, and immunophenotype, and the discrete large cell transformation occasionally seen in B-cell lymphoma and extranodal T- cell lymphoma was not observed in these cases.